Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
This article was originally published in The Rose Sheet
Jim O'Neill, a Silicon Valley investment manager, would be an unusual choice to head FDA, not just because he isn’t a physician, but because he’s favored substantially reducing FDA's role in assessing product effectiveness. While some experts are highly skeptical about O'Neill, who worked at HHS in the Bush administration, others suggest he could champion much-needed change at the agency.
You may also be interested in...
FDA Commish Nominee Could Be Mixed Blessing For Cosmetics Industry
Physician and former FDA official Scott Gottlieb, nominated by President Trump to head up the agency, is a more conventional pick for the role than other reportedly short-listed individuals. His science background checks a box on the cosmetics industry’s wish list, but he also – like Trump – has been a proponent of cutting red tape, while cosmetics players are actually seeking more involved federal oversight.
Trump Meets With Two FDA Commissioner Candidates; Third Still In Play
O'Neill and Srinivasan head to Trump Tower, but Gottlieb has not been eliminated.
Will US FDA Wind Up With More Political Positions Under Trump?
Incoming administration could appoint key legal and policy positions to shape agenda’s agenda.